AI in clinical trials holds great promise for the entire drug development lifecycle. However, any new technology should ...

For Europe to remain an attractive site for phase 3 research, he argued, regulatory predictability is paramount. El-Galaly ...

A New York Times health reporter explains what clinical trials are, why they are important and how they can help inform us. Credit...Ricardo Tomás Supported by By Nina Agrawal Nina Agrawal is a health ...

Industry groups have asked the US Food and Drug Administration (FDA) to provide more clarity about its regulatory approach to ...

The clinical trial landscape is continually adapting its focus on patient-centric practices to improve clinical trial participation by reducing patients' burden. Over the past few years, this shift ...

Applied Biologics, a biopharmaceutical company advancing novel biologic therapies for chronic wounds, tissue repair, and degenerative disease, presented interim clinical data from the CAMPX Trial at ...

Clinical trials rarely fail overnight, but when recruitment slows, timelines slip and budgets tighten, recovery becomes increasingly complex. This webinar will provide practical, actionable strategies ...

Lupus Nephritis Clinical Trial Landscape Becomes Increasingly Crowded with 30+ Pharma Companies | DelveInsight The lupus nephritis clinical trial analysis report delivers important insights into ...

Clinical trial names span a broad range, from straightforward acronyms to more inspiring titles—see: Eli Lilly’s optimistically dubbed family of Triumph trials—to the downright ostentatious, like ...

Oculis is a proud sponsor of Clinical Trials at the Summit 2026, which brings together experts from around the world to discuss ongoing clinical trials and the latest data, all with the goal of ...